In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agents.
about
Activity of fleroxacin alone and in combination with clindamycin or metronidazole in experimental intra-abdominal abscessesFactors influencing elimination and distribution of fleroxacin: metaanalysis of individual data from 10 pharmacokinetic studiesPharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis.Renal handling of fleroxacin in rabbits, dogs, and humans.Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteersDouble-blind, dose-range-finding study of fleroxacin (RO 23-6240; AM-833) for treatment of complicated urinary tract infections.Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis.Pharmacokinetics and biliary concentrations of fleroxacin in cholecystectomized patientsFleroxacin (Ro 23-6240) distribution in canine prostatic tissue and fluids.Susceptibility of Staphylococcus species and subspecies to fleroxacinPenetration of moxifloxacin into bone evaluated by Monte Carlo simulation.Developments in quinolones. Bacteriology, pharmacokinetics and initial clinical experience of several investigational quinolone derivatives.Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions.In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents.Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone.Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans.Fleroxacin pharmacokinetics in patients with liver cirrhosisPharmacokinetics of 18F-labeled fleroxacin in rabbits with Escherichia coli infections, studied with positron emission tomography.Comparison of fleroxacin and penicillin G plus probenecid in the treatment of acute uncomplicated gonococcal infections.Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivative.
P2860
Q33748818-7419A356-64E5-403A-8D13-8E38D9058434Q35122861-F75F57F2-BA39-4655-B54E-D37C1A62B04BQ35245010-C1340B01-CE50-4011-9F4C-BDA55ACB85EDQ35245673-AA53C072-CEBC-4705-A48C-50CC34C64858Q35245897-577C0216-9A13-41BC-B3C8-B4B1E565DFEEQ35250121-492DF608-7D8B-4A5C-B646-EBF088F11B60Q35276315-F14098A2-DD64-41AF-94ED-5E44DA614A8CQ35285443-CCA11E75-2DFA-422C-9204-EDC0C8BE0418Q35540757-7048A17A-EA03-4D1B-BA75-C9A5F32EFC10Q36756084-C142912F-F3F4-4D93-AC1F-A4331C732B0CQ37190660-60056853-EE6C-4C27-80EA-A4F567DAC0FDQ38635746-B5C230C9-CD91-491D-83CA-E4EC43FDB9BEQ39214819-69210DE6-E436-438D-BB9E-3CB85C7B0BAEQ39818110-55AAD5E7-BD36-4F9B-ADF3-3E519384F93AQ39827591-7CADB5F1-DE16-443C-8E8D-DCFC2F895F5CQ39832115-45EDBB5B-750D-46A1-BA54-F4CDDC015812Q39875877-4DF0A823-59D8-444F-8409-EF8741D4CF6EQ40088633-D0022DBF-AB1A-484B-9064-91099B007539Q41943559-BEC6EC97-50B3-4D49-A1EE-E3FE030F04F5Q45245312-ACAB7EC7-2537-4604-9B90-700EE18BD321
P2860
In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agents.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
In vitro activity of Ro 23-624 ...... of other antimicrobial agents.
@en
In vitro activity of Ro 23-624 ...... of other antimicrobial agents.
@nl
type
label
In vitro activity of Ro 23-624 ...... of other antimicrobial agents.
@en
In vitro activity of Ro 23-624 ...... of other antimicrobial agents.
@nl
prefLabel
In vitro activity of Ro 23-624 ...... of other antimicrobial agents.
@en
In vitro activity of Ro 23-624 ...... of other antimicrobial agents.
@nl
P2093
P2860
P356
P1476
In vitro activity of Ro 23-624 ...... of other antimicrobial agents.
@en
P2093
P2860
P304
P356
10.1128/AAC.30.2.330
P407
P577
1986-08-01T00:00:00Z